US2022119873A1PendingUtilityA1
Karyotyping assay
Est. expiryMay 14, 2030(~3.8 yrs left)· nominal 20-yr term from priority
C12Q 1/6844
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to methods and kits for karyotyping in which chromosomes are interrogated by amplifying loci that are not within copy number variable regions thereof.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A composition comprising:
a plurality of oligonucleotide probes, wherein each probe has a portion that is specific for at least one target locus in at least one chromosome, wherein the target locus is located on a region of the chromosome that is not within a copy number variable region (CNVR), and wherein each probe includes a detectable label.
23 . The composition of claim 22 , wherein the plurality of oligonucleotide probes are immobilized on a solid support.
24 . The composition of claim 22 , wherein the plurality of oligonucleotide probes comprise subsets of probes that are specific for at least two target loci outside of a CNVR from at least one chromosome.
25 . The composition of claim 22 , wherein the at least one chromosome is selected from human chromosomes 1-22, X and Y.
26 . The composition of claim 22 , wherein the oligonucleotide probes are selected from the group consisting of SEQ ID NO: 193-288.
27 . The composition of claim 22 , further comprising a first pair of primers configured to target a first target locus outside of a CNVR and enable formation of a first amplification product, wherein at least a first probe of the plurality of oligonucleotide probes is configured to hybridize to the first amplification product.
28 . (canceled)
29 . The composition of claim 27 , further comprising at least one additional set of primers corresponding to a reference test locus.
30 - 35 . (cancelled)
36 . The composition of claim 27 , wherein each primer of the first pair of primers are selected from the group consisting of SEQ ID NO: 1-192.
37 . The composition of claim 22 , wherein the at least one chromosome is selected from human chromosomes 1, 5, 13, 18, 21, X and Y.
38 . The composition of claim 22 , wherein at least one of the plurality of oligonucleotide probes includes a minor groove binder (MGB).
39 . The composition of claim 22 , wherein the detectable label comprises a fluorescent label and a quencher molecule capable of quenching the fluorescence of said fluorescent label.
40 . The composition of claim 27 , further comprising a second pair of primers configured to target a second target locus outside of a CNVR and enable formation of a second amplification product, wherein at least at least a second probe of the plurality of oligonucleotide probes is configured to hybridize to the second amplification product.
41 . The composition of claim 40 , wherein the first target locus and the second target locus are located on separate arms of the same chromosome.
42 . A composition comprising:
a first pair of primers configured to target a first target locus outside of a copy number variable region (CNVR) and enable formation of a first amplification product; a second pair of primers configured to target a second target locus outside of a CNVR and enable formation of a second amplification product; a first probe configured to hybridize to the first amplification product, the first probe comprising a detectable label; and a second probe configured to hybridize to the second amplification product, the second probe comprising a detectable label.
43 . The composition of claim 42 , wherein the detectable labels of the first and second probes are different.
44 . The composition of claim 42 , wherein each of the detectable labels comprise a fluorescent label and a quencher molecule capable of quenching the fluorescence of said fluorescent label.
45 . The composition of claim 42 , wherein each primer of the first and second pairs of primers are selected from the group consisting of SEQ ID NO: 1-192.
46 . The composition of claim 42 , wherein the first and second probes are selected from the group consisting of SEQ ID NO: 193-288.Join the waitlist — get patent alerts
Track US2022119873A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.